(North America, South America, and the Caribbean)
(Including Hong Kong SAR, Macau SAR, and Taiwan)
Published on August 23, 2023, in the prestigious journal Nature, a study led by Dr Kazuo Isozaki, alongside teams from renowned oncology research centers, explored the intriguing evolution of resistance mutations in non-small cell lung cancers (NSCLCs) treated with tyrosine kinase inhibitors (TKIs). The research in this paper focused on the following key questions:
Download Now
The field is required.
I agree that Novogene Corporation may use this information to contact me to assist with my request. I understand that all personal information I have submitted will be kept confidential in accordance with Novogene's privacy policy.